The competitive and/or cooperative interactions between SETD2‐deficient cells and other tumor subclones that result from ITH, and how these interactions impact growth properties of neighboring cancer cells or the tumor as a whole through non‐cell autonomous mechanisms remains to be determined. This evidence concerns the gene SETD2 and neoplasm.